These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8991040)

  • 61. Inter-assay and instrument variability of anti-Xa--results.
    Kovacs MJ; Keeney M
    Thromb Haemost; 2000 Jul; 84(1):138. PubMed ID: 10928485
    [No Abstract]   [Full Text] [Related]  

  • 62. Danaparoid sodium in diabetic retinopathy.
    Gambaro G
    Lancet; 1998 Feb; 351(9103):674. PubMed ID: 9500356
    [No Abstract]   [Full Text] [Related]  

  • 63. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
    Gurbuz AT; Elliott WG; Zia AA
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost effectiveness of danaparoid compared with enoxaparin as deep vein thrombosis prophylaxis after hip replacement surgery.
    Wade WE
    Am J Orthop (Belle Mead NJ); 1999 Apr; 28(4):229-31. PubMed ID: 10220094
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Danaparoid in pregnancy in cases of heparin intolerance - use in 59 cases].
    Schindewolf M; Magnani HN; Lindhoff-Last E
    Hamostaseologie; 2007 May; 27(2):89-97. PubMed ID: 17479171
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Two cases of valvular thrombosis secondary to heparin-induced thrombocytopenia managed without surgery.
    Ricome S; Provenchere S; Aubier B; Ajzenberg N; Lepage L; Dilly MP; Dufour G; Montravers P; Longrois D
    Circulation; 2011 Mar; 123(12):1355-7. PubMed ID: 21444894
    [No Abstract]   [Full Text] [Related]  

  • 67. Vascular drugs in the new millennium.
    Frangos SG; Chen AH; Sumpio B
    J Am Coll Surg; 2000 Jul; 191(1):76-92. PubMed ID: 10898187
    [No Abstract]   [Full Text] [Related]  

  • 68. Hitting back HIT.
    Gude D
    Ann Card Anaesth; 2012; 15(2):168-9. PubMed ID: 22508216
    [No Abstract]   [Full Text] [Related]  

  • 69. [A case of portal vein thrombosis complicating acute cholangitis treated successfully with danaparoid sodium].
    Oku T; Kubo Y; Miseki T; Sakai T; Yamakawa A; Sugata H
    Nihon Shokakibyo Gakkai Zasshi; 2010 Nov; 107(11):1814-20. PubMed ID: 21071899
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Danaparoid sodium for dialysis in heparin-associated thrombocytopenia].
    Ben Ami R; Rachmimov R; Berliner S
    Harefuah; 1999 Mar; 136(5):361-4, 419. PubMed ID: 10914239
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [An operated case of retroperitoneal venous hemangioma complicated with Kasabach-Merritt syndrome which was well controlled by danaparoid sodium].
    Moriguchi A; Iwahashi K; Onishi Y; Kita H; Nishio A; Kanno T; Matsuura T; Ikezawa K; Ono A; Mizuno T; Chiba M; Maeda K; Aketa H; Naito M; Michida T; Katayama K; Yamasaki Y; Kasugai T
    Nihon Shokakibyo Gakkai Zasshi; 2009 Nov; 106(11):1660-8. PubMed ID: 19893297
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New treatment options for heparin-induced thrombocytopenia.
    Ortel TL; Chong BH
    Semin Hematol; 1998 Oct; 35(4 Suppl 5):26-34; discussion 35-6. PubMed ID: 9855181
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Heparin-induced thrombocytopenia (HIT). A report of 1,478 clinical outcomes of patients treated with danaparoid (Orgaran) from 1982 to mid-2004.
    Magnani HN; Gallus A
    Thromb Haemost; 2006 Jun; 95(6):967-81. PubMed ID: 16732376
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Treatment by danaparoid sodium for portal venous thrombosis].
    Shudo R; Yazaki Y; Sugawara K; Honda M
    Nihon Shokakibyo Gakkai Zasshi; 2007 Feb; 104(2):205-12. PubMed ID: 17283415
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

  • 76. [Thrombosis, low-molecular-weight heparin-induced thrombocytopenia and labor].
    Lemesle FG; Mebroukine L; Ermacora P; Lhuillier P; Marfaing A; Wolf M
    Presse Med; 1998 Jan; 27(1):19. PubMed ID: 9767759
    [No Abstract]   [Full Text] [Related]  

  • 77. Cost-effectiveness of venous thrombosis prophylaxis following ischemic stroke: an assessment of currently available literature.
    Wade WE
    Thromb Res; 1998 Feb; 89(4):199-202. PubMed ID: 9651147
    [No Abstract]   [Full Text] [Related]  

  • 78. [Successful use of danaparoid in the treatment of portal vein thrombosis that developed in a warfarin-administered hepatitis C virus-related cirrhosis patient].
    Nawata Y; Hamada K; Tajima H; Nishino N; Nakazawa T; Tobayashi K; Saitoh S
    Nihon Shokakibyo Gakkai Zasshi; 2012 Aug; 109(8):1394-400. PubMed ID: 22863964
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modern aspects of prophylaxis and therapy for venous thrombo-embolic disease.
    Bergqvist D
    Aust N Z J Surg; 1998 Jul; 68(7):463-8. PubMed ID: 9669358
    [No Abstract]   [Full Text] [Related]  

  • 80. [Diagnosis, pathogenesis and latest therapy in portal hypertension].
    Kokubu S
    Nihon Shokakibyo Gakkai Zasshi; 2008 Nov; 105(11):1588-96. PubMed ID: 18987443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.